2Litwin SM, Mcnaughton Collins M, Fowler FJ, et al. The NIH chronic prostatitis symptom index(NIH-CPSI): Development and validation of anew outcomes measure[J]. J Urol, 1999, 162(2):369-375. 被引量：1
3[1]Collins MM, Stafford RS, O' leary MP, et al. How common is Prostatitis? A national survery of physician visits [J]. J Urol, 1998, 159:1224-1228. 被引量：1
4[3]Litwin MS, Mcvaughto- Collins M, Fowler FJ Jr et al. The National Institutes of Health chronic prostatitis symphtom index: development and validation of a new outcome measure[J]. J Urol, 1999, 162(2):369- 375. 被引量：1
5[4]Fukuda K, Hibiya Y, Mutoh M, et al. Inhibition by berberine of cyclooxygenase - 2 transcriptional activity in human colon cancer cells[J]. J Ethnopharmacol, 1999, 66(2):227- 233. 被引量：1
8Krieger JN, Nyberg L, Nickel JC. NIH consensus definition and classification of prostatitis [5]. JAMA 1999; 282(3): 236-237. 被引量：1
9Litwin MS, McNaughton CM, Fowler Jr, FJ, et al.The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure, J Urol 1999; 162(2): 369-375. 被引量：1
10Nickel JC, Nigro M, Valiquette L, et al. Diagnosis and treatment of prostatitis in Canada. Urology 1998; 52(5): 797-802. 被引量：1
